ロード中...
4CPS-150 Use of adalimumab for hidradenitis suppurativa
BACKGROUND: Adalimumab is an antibody against tumour necrosis factor-α currently indicated for moderate to severe hidradenitis suppurative (HS). PURPOSE: To assess the effectiveness and safety of adalimumab in patients with HS. MATERIAL AND METHODS: A retrospective study of patients with HS and trea...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535183/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.241 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|